Hemfosa Fastigheter acquires healthcare property in Sweden for MSEK 195
![](https://mb.cision.com/Public/7964/2036982/8422f2d195da827a_800x800ar.jpg)
Hemfosa has signed an agreement concerning the acquisition of a healthcare property in Vällingby, just outside Stockholm, at a value of MSEK 195. This is the second major acquisition in Sweden that Hemfosa has completed during the second quarter of this year. The company’s ambition is to continue to expand its portfolio of community service properties in all three Nordic markets. Praktikertjänst Fastigheter AB is the seller.
The healthcare property, which is a site leasehold, is centrally located in Vällingby. Leasable floor space amounts to approximately 6,000 square meters. The average lease extends for about 5.3 years, and the rental value amounts to approximately MSEK 15.0 per year. The leasing rate is 98 percent and the largest tenants are Praktikertjänst and Aleris, both of which offer local medical services in the property.
“The healthcare property in Vällingby has established healthcare providers as tenants and stable cash flows. It is well-suited to Hemfosa’s growing portfolio of community service properties,” says Stina Lindh Hök, Head of Transactions at Hemfosa.
Possession is scheduled for September 1, 2016.
For further information, please contact:
Stina Lindh Hök, Head of Transactions, stina.lindh.hok@hemfosa.se, mobile +46 70 577 18 85, office +46 8 448 04 80
About Hemfosa Fastigheter
Hemfosa is a Swedish property company focusing on community service properties in the Nordic region with its largest tenants being the Swedish state and municipalities. This provides stable cash flows and a healthy yield. In order to create value, Hemfosa also aims to actively participate in the transaction market. As per March 31, 2016, Hemfosa owned properties with a total property value of approximately SEK 32.6 billion, including the company’s share of the property value in joint ventures. Hemfosa’s common share has been listed since March 2014 and its preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.
Tags: